Peter Hendricks

Director of Psychedelic Studies · University of Alabama Hospital

Credentials: · ·

History

Psilocybin in the Treatment of Methamphetamine Use Disorder
National Institute on Drug Abuse · UG3
Contact PI · $662.3K · University of Alabama at Birmingham
2026–2028
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
National Institute on Drug Abuse · R01
Contact PI · $3.1M · University of Alabama at Birmingham
2019–2026
The Time Course and Clinical Significance of Early E-Cigarette Withdrawal Effects
National Institute on Drug Abuse · R01
Contact PI · $1.8M · University of Alabama at Birmingham
2014–2021
Withdrawal Exposure with Withdrawal Regulation Training for Smoking Cessation
National Institute on Drug Abuse · R34
Contact PI · $650.5K · University of Alabama at Birmingham
2011–2015

Psilocybin for Methamphetamine Use Disorder
Principal investigator · Not yet recruiting · Phase 2
Peter Hendricks
2027–2032
Psilocybin-facilitated Treatment for Cocaine Use
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham
2015–2024
Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation
Principal investigator · Completed
University of Alabama at Birmingham
2011–2014
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Site PI · Recruiting · Phase 3
Cybin IRL Limited
2025–2027